This is particularly consequential for antibody portfolio management, where parent applications often describe broad epitope-binding characteristics before the specific CDR sequences of the most commercially valuable antibodies are fully characterized
Wang L, Xu R, Kaelber DC, Berger NA
Eli Lilly Moves Closer To Another Weight-Loss Drug: Retatrutide Clears Two More Phase 3 Trials Ahead Of FDA Filing Lilly said it plans to submit a Biologics License Application to the U.S
Withdraw the prescribed volume (e.g., 0.25, 0.5, 0.75 or 1 mL) into a sterile syringe and inject subcutaneously in the abdomen, thigh, or upper arm after cleaning the site with alcohol
I could also view all available meals for that week
Eli Lilly is separately advancing oral formulations that could expand its reach to patients who prefer not to use injections